Myopia is a highly frequent ocular disorder worldwide and pathologic myopia is the 4th most
common cause of irreversible blindness in developed countries. Pathologic myopia is …

Myopic choroidal neovascularization (CNV) is one of the leading causes of visual
impairment worldwide. The clinical and socioeconomic impact of myopic CNV in Asian …

Topic The aim of this article is to review and compile available information on the
classification, pathophysiology, and clinical features of myopic choroidal neovascularization …

Pathological myopia is a major cause of irreversible vision loss and is the fourth to ninth
most frequent cause of blindness in the world. Choroidal neovascularization (CNV) …

Background: Intravitreal ranibizumab and pegaptanib are registered for neovascular age-
related macular degeneration. No formal safety study has been conducted for intravitreal …

Purpose To evaluate the long-term efficacy of intravitreal anti-vascular endothelial growth
factor (anti-VEGF) therapy as primary treatment for subfoveal myopic choroidal …

Background: Pathologic myopia is the second cause of choroidal neovascularization, after
age-related macular degeneration (AMD), and the first cause in patients younger than 50 …

Purpose: To evaluate the efficacy of intravitreal ranibizumab for the primary treatment of
myopic choroidal neovascularization (CNV). Methods: Sixteen eyes of 16 consecutive …

Methods: The authors conducted comprehensive search in PubMed, EMBASE, Cochrane
Library, Biosis Preview, and LILACS. Included studies were categorized by study design …

Purpose: The purpose of this study was to evaluate the safety and efficacy of intravitreal
ranibizumab after 12 months in the treatment of choroidal neovascularization secondary to …